This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1998 Oct;22(10):1239-46.

doi: 10.1097/00000478-199810000-00009.

Pseudohyperplastic prostatic adenocarcinoma

P A Humphrey¹, Z Kaleem, P E Swanson, R T Vollmer

Affiliations

PMID: 9777986
DOI: 10.1097/00000478-199810000-00009

Comparative Study

Pseudohyperplastic prostatic adenocarcinoma

P A Humphrey et al. Am J Surg Pathol. 1998 Oct.

. 1998 Oct;22(10):1239-46.

doi: 10.1097/00000478-199810000-00009.

Authors

P A Humphrey¹, Z Kaleem, P E Swanson, R T Vollmer

Affiliation

¹ Department of Pathology, Washington University Medical Center, St. Louis, Missouri 63110, USA.

PMID: 9777986
DOI: 10.1097/00000478-199810000-00009

No abstract available

PubMed Disclaimer

Similar articles

[Pathologic characteristics of pseudohyperplastic prostatic adenocarcinoma].
Zhang HZ, Jiang ZM, Shi L. Zhang HZ, et al. Zhonghua Bing Li Xue Za Zhi. 2007 Nov;36(11):742-5. Zhonghua Bing Li Xue Za Zhi. 2007. PMID: 18307877 Chinese.
Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy.
Levi AW, Epstein JI. Levi AW, et al. Am J Surg Pathol. 2000 Aug;24(8):1039-46. doi: 10.1097/00000478-200008000-00001. Am J Surg Pathol. 2000. PMID: 10935644
[The morphogenesis of cancer of the prostate (immunohistochemical research)].
Vorobĭova LR. Vorobĭova LR. Lik Sprava. 1998 May;(3):87-90. Lik Sprava. 1998. PMID: 9695575 Ukrainian.
Atypical small acinar proliferation in the prostate: clinical significance in 2006.
Bostwick DG, Meiers I. Bostwick DG, et al. Arch Pathol Lab Med. 2006 Jul;130(7):952-7. doi: 10.5858/2006-130-952-ASAPIT. Arch Pathol Lab Med. 2006. PMID: 16831049 Review.
Benign mimics of prostatic adenocarcinoma on needle biopsy.
Gaudin PB, Reuter VE. Gaudin PB, et al. Anat Pathol. 1997;2:111-34. Anat Pathol. 1997. PMID: 9575372 Review.

See all similar articles

Cited by

Evaluation of routine application of P504S, 34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens.
Pavlakis K, Stravodimos K, Kapetanakis T, Gregorakis A, Athanassiadou S, Tzaida O, Constantinides C. Pavlakis K, et al. Int Urol Nephrol. 2010 Jun;42(2):325-30. doi: 10.1007/s11255-009-9622-1. Epub 2009 Aug 5. Int Urol Nephrol. 2010. PMID: 19655267
Do prostatic transition zone tumors have a distinct morphology?
Garcia JJ, Al-Ahmadie HA, Gopalan A, Tickoo SK, Scardino PT, Reuter VE, Fine SW. Garcia JJ, et al. Am J Surg Pathol. 2008 Nov;32(11):1709-14. doi: 10.1097/PAS.0b013e318172ee97. Am J Surg Pathol. 2008. PMID: 18769336 Free PMC article.
Histopathology of Prostate Cancer.
Humphrey PA. Humphrey PA. Cold Spring Harb Perspect Med. 2017 Oct 3;7(10):a030411. doi: 10.1101/cshperspect.a030411. Cold Spring Harb Perspect Med. 2017. PMID: 28389514 Free PMC article. Review.
Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini-review of plasmacytoid features in the genitourinary system: A case report.
Zacharouli K, Vageli DP, Koukoulis GK, Ioannou M. Zacharouli K, et al. Mol Clin Oncol. 2022 Mar;16(3):67. doi: 10.3892/mco.2022.2500. Epub 2022 Jan 20. Mol Clin Oncol. 2022. PMID: 35154707 Free PMC article.
Comparison of Immunohistochemistry Expression of CK7, HMWK and PSA in High-Grade Prostatic Adenocarcinoma and Bladder Transitional Cell Carcinoma.
Gheitasi R, Sadeghi E, Jafari M. Gheitasi R, et al. Iran J Pathol. 2021 Winter;16(1):33-39. doi: 10.30699/ijp.2020.123998.2353. Epub 2020 Nov 13. Iran J Pathol. 2021. PMID: 33391378 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information